The CJEU abolishes Neurim and SPCs for new therapeutic indications.
- Published in:
- Journal of Intellectual Property Law & Practice, 2021, v. 16, n. 2, p. 94, doi. 10.1093/jiplp/jpab001
- By:
- Publication type:
- Article
Works matching DE "SANTEN SAS"
Results: 2
1
2
Santen SAS uses Nanoparticle Tracking Analysis to study nanoemulsions used in new ophthalmic & pharmaceutical products.
- Published in:
- infocus Magazine, 2013, n. 32, p. 83
- Publication type:
- Article